Latest Oligonucleotide Stories
A new method of manufacturing short, single-stranded DNA molecules can solve many of the problems associated with current production methods.
Leading Biotechnology Manufacturer NITTO DENKO Avecia Inc.
This program will assess the therapeutic potential of second-generation Antisense Oligonucleotides (ASO) sequences for SMA. This funding is being awarded to Co-Principal Investigators Dr.
- The governor of a province or people.